(HealthDay News) — Oral systemic agomelatine has a hypotensive effect that decreases intraocular pressure (IOP) in both eyes of treatment-resistant primary open angle glaucoma (POAG) patients, ...
Please provide your email address to receive an email when new articles are posted on . Agomelatine proved safe and effective in treating adolescents with major depressive disorder who received ...
June 21, 2005 (Pittsburgh) — Patients with bipolar depression may get relief from the adjunctive use of agomelatine (Valdoxan), according to U.S. and French investigators who presented their findings ...
MOUNTAIN VIEW, Calif. - Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company currently valued at $74 million, has announced at the American Society of Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback